Gemtuzumab ozogamicin
About
Therapy type: Immunotherapy
Therapy strategy: CD33 inhibition
Mappings
NCI Thesaurus: Gemtuzumab Ozogamicin (ncit:C1806)
RxNorm: gemtuzumab ozogamicin (rxcui:1294580, omop:42799711)
SNOMED: Gemtuzumab ozogamicin (sctid:127964000, omop:4027914)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
| Organization(s) | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| FDA (2) | CD33 + | Acute Lymphoid Leukemia | Gemtuzumab ozogamicin | |
| EMA (1) | CD33 + | Acute Myeloid Leukemia | Cytarabine, Daunorubicin, Gemtuzumab ozogamicin | |
| HSE (1) | CD33 + | Acute Lymphoid Leukemia | Cytarabine, Daunorubicin, Gemtuzumab ozogamicin |